These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 38116472)

  • 21. Toxin Neutralization Using Alternative Binding Proteins.
    Jenkins TP; Fryer T; Dehli RI; Jürgensen JA; Fuglsang-Madsen A; Føns S; Laustsen AH
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity.
    Krause KE; Jenkins TP; Skaarup C; Engmark M; Casewell NR; Ainsworth S; Lomonte B; Fernández J; Gutiérrez JM; Lund O; Laustsen AH
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008366. PubMed ID: 32579606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current research into snake antivenoms, their mechanisms of action and applications.
    Silva A; Isbister GK
    Biochem Soc Trans; 2020 Apr; 48(2):537-546. PubMed ID: 32196542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
    Laustsen AH; Johansen KH; Engmark M; Andersen MR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Need for Next-Generation Antivenom for Snakebite Envenomation in India.
    Vanuopadath M; Rajan K; Alangode A; Nair SS; Nair BG
    Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries.
    Patikorn C; Ismail AK; Abidin SAZ; Blanco FB; Blessmann J; Choumlivong K; Comandante JD; Doan UV; Mohamed Ismail Z; Khine YY; Maharani T; Nwe MT; Qamruddin RM; Safferi RS; Santamaria E; Tiglao PJG; Trakulsrichai S; Vasaruchapong T; Chaiyakunapruk N; Taychakhoonavudh S; Othman I
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35296460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commercial Antivenoms Exert Broad Paraspecific Immunological Binding and In Vitro Inhibition of Medically Important
    Alsolaiss J; Alomran N; Hawkins L; Casewell NR
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy.
    Knudsen C; Casewell NR; Lomonte B; Gutiérrez JM; Vaiyapuri S; Laustsen AH
    Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32824899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.
    Alomran N; Chinnappan R; Alsolaiss J; Casewell NR; Zourob M
    Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advancements in snake antivenom production.
    Rathore AS; Kumar R; Tiwari OS
    Int J Biol Macromol; 2023 Jun; 240():124478. PubMed ID: 37072061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation.
    Patra A; Herrera M; Gutiérrez JM; Mukherjee AK
    Drug Test Anal; 2021 Aug; 13(8):1471-1489. PubMed ID: 34089574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Snakebite envenoming from a global perspective: Towards an integrated approach.
    Gutiérrez JM; Williams D; Fan HW; Warrell DA
    Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antivenoms for the treatment of snakebite envenomings: the road ahead.
    Gutiérrez JM; León G; Burnouf T
    Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
    Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralization capacity of recombinant antivenoms based on monoclonal antibodies and nanobodies.
    Ljungars A; Laustsen AH
    Toxicon; 2023 Jan; 222():106991. PubMed ID: 36481349
    [No Abstract]   [Full Text] [Related]  

  • 40. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.